Clinical Trial Update: A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated two dosing schedules of trabectedin in patients with advanced liposarcoma or leiomyosarcoma; the study has completed and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma

Drugs mentioned

• Trabectedin (Yondelis) (trabectedin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Liposarcoma, Leiomyosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2014-09-08